You are here
The Ohio State University College of Pharmacy awards The Ohio State University Comprehensive Cancer Center Friend of the College Award
COLUMBUS, OH – The Ohio State University College of Pharmacy presented The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) with the Friend of the College Award at a ceremony on Thursday, April 6, 2017. Michael Caligiuri, MD, director of the OSUCCC and chief executive officer of the James Cancer Hospital and Solove Research Institute accepted the award on the OSUCCC – James’ behalf.
The Friend of the College Award recognizes an individual or organization for continuous thoughtful contributions to the growth and success of the College of Pharmacy through ongoing service and support of the Ohio State Pharmacy Alumni Society and its students, faculty, and staff. The award is only given when truly outstanding candidates are identified.
Henry Mann, PharmD, dean of Ohio State’s College of Pharmacy said, “It is hard to think of a candidate more deserving of this award than the OSUCCC – James. The OSUCCC – James has always valued the partnership between researchers and physicians to discover breakthroughs in medicine, and we take the trust the cancer center places in the college very seriously.”
The OSUCCC – James and the College of Pharmacy have a long history of collaboration in cancer research. The cancer center has helped the college to recruit and retain top-level faculty who are making groundbreaking discoveries at the university. Most recently, the OSUCCC – James helped to recruit four faculty members, Drs. Sharyn Baker, Raj Govindarajan, Navjot Pabla, and Alex Sparreboom to the Division of Pharmaceutics and Pharmaceutical Chemistry.
When presented with the award, Dr. Caligiuri thanked the College of Pharmacy and reaffirmed the tremendous collaboration between the organizations. Dr. Caligiuri also recognized Michael Grever, MD, FACP, as a strong advocate for the partnership between the College of Pharmacy and the OSUCCC – James.
Dr. Grever came to Ohio State in 1978, starting as an assistant professor of medicine. In July of this year, Dr. Grever will retire as chairman of the department of internal medicine, a position he has held for the past 17 years.
An authority on anti-cancer drug development and experimental therapeutics, Dr. Grever often partnered with faculty of the College of Pharmacy in the course of his research and was impressed by the high caliber of work. Specifically, Dr. Grever worked very closely with Dr. Lou Malspeis of the College of Pharmacy on several NCI grants and contracts relating to new chemotherapeutic drugs for leukemia from approximately 1978 to 1990. When he returned to Ohio State in the early 2000’s, Dr. Grever was helpful in recruiting cancer research faculty to the College of Pharmacy, meeting with Dr. Ching-Shih Chen and Dr. Doug Kinghorn. His fondness for the college has been an asset that can’t be understated.
“We are immensely grateful for the OSUCCC – James and their engagement with the College of Pharmacy. Our college is exploring new frontiers in drug discovery and development, pharmaceutical sciences, and translational clinical research. This work is significantly strengthened by the OSUCCC – James. At the end of the day, we are working toward the same mission – to improve health and well-being,” Mann said.